Drug Targets for Fungal-Associated Respiratory Disorders

Description:

Proteins from the fungus Alternaria have importance in the pathogenesis of some chronic respiratory allergies and disorders. This technology identifies fungal proteins that are critical for the onset of these diseases and are potential drug targets.

US Patent 7,662,400

US Patent 7,887,820

US Patent 7,972,611

Patent Information:

Title	App Type	Country	Serial No.	Patent No.	File Date	Issued Date	Expire Date	Patent Status
Fungus-Induced Inflammation and Eosinophil Degranulation	US Utility	*United States	11/580,454	7,662,400	10/13/2006	2/16/2010	3/17/2027	Issued
Fungus-Induced Inflammation and Eosinophil Degranulation	US Divisional	*United States	12/835,592	7,887,820	7/13/2010	2/15/2011	10/13/2026	Issued
Fungus-Induced Inflammation and Eosinophil Degranulation	US Divisional	*United States	12/973,100	7,972,611	12/20/2010	7/5/2011	10/14/2025	Issued

Direct Link:

http://vtip.technologypublisher.com/technology/10422

Category(s):

Drug Screening

Bookmark this page

Download as PDF

For Information, Contact:

Mike Miller

Senior Licensing Manager

Virginia Tech Intellectual Properties, Inc.

(540) 443-9228

mmiller@vtip.org

Inventors:

Christopher Lawrence

Keywords:

Pharmaceuticals & Biotechnology